Pathophysiological study of chronic necrotizing pulmonary aspergillosis

Japanese Journal of Infectious Diseases

Volumn 61, Issue 6, 2008, Pages 450-453

  Sugino, Keishi ^a   Hasegawa, Chikako ^a   Sano, Go ^a   Shibuya, Kazutoshi ^a   Homma, Sakae ^a  

^a TOHO UNIVERSITY OMORI MEDICAL CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHOTERICIN B DEOXYCHOLATE; BETA GLUCAN; CORTICOSTEROID; ERYTHROMYCIN; FUNGUS ANTIBODY; GALACTOMANNAN; ITRACONAZOLE; MICAFUNGIN; PREDNISOLONE; SPARFLOXACIN; ANTIFUNGAL AGENT;

AGED; ANAMNESIS; ARTICLE; ASTHMA; CASE REPORT; CHRONIC NECROTIZING PULMONARY ASPERGILLOSIS; CLINICAL FEATURE; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; DYSPNEA; FATIGUE; FEMALE; FEVER; GRANULATION TISSUE; HEMOPTYSIS; HEPATITIS C; HISTOPATHOLOGY; HUMAN; IMMUNOPRECIPITATION; LUNG ASPERGILLOSIS; LUNG FIBROSIS; LUNG TUBERCULOSIS; MALE; MORTALITY; MYCETOMA; PATHOPHYSIOLOGY; RESPIRATORY FAILURE; SINGLE DRUG DOSE; THORAX RADIOGRAPHY; THROMBOSIS; TISSUE NECROSIS; TUMOR VOLUME; WHEEZING; ASPERGILLUS; FATALITY; ISOLATION AND PURIFICATION; LUNG; LUNG MYCOSIS; MICROBIOLOGY; PATHOLOGY; RADIOGRAPHY;

AGED; ANTIFUNGAL AGENTS; ASPERGILLUS; FATAL OUTCOME; FEMALE; HEMOPTYSIS; HUMANS; INVASIVE PULMONARY ASPERGILLOSIS; LUNG; LUNG DISEASES, FUNGAL; MALE;

EID: 58149388286     PISSN: 13446304     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Binder, R.E., Faling, L.J., Pugatch, R.D., et al. (1982): Chronic necrotizing pulmonary aspergillosis: a discrete clinical entity. Medicine, 61, 109-124.
2. Yousem, S.A. (1997): The histological spectrum of chronic necotizing forms ofpulmonary aspergillosis. Hum. Pathol., 28, 650-656.
3. Gefter, W.B., Weingrad, T.R., Epstein, D.M., et al. (1981): Semi-invasive pulmonary aspergillus. Radiology, 140, 313-321.
4. Soubani, A.O. and Chandrasekar, P.H. (2002): The clinical spectrum of pulmonary aspergillosis. Chest, 121, 1988-1999.
5. Saraceno, J.L., Phelps, D.T., Ferro, T.J., et al. (1997): Chronic necrotizing pulmonary aspergillosis: approach to management. Chest, 112, 541-548.
6. Kohno, S., Masaoka, T., Yamaguchi, H., et al. (2004): A multicenter, open-label clinical study of micafungin (FK463) in the treatment of deep-seated mycosis in Japan. Scand. J. Infect. Dis., 36, 372-379.
7. Shibuya, K., Ando, T., Wakayama, M., et al. (1997): Pathological spectrum of invasive pulmonary aspergillosis. Jpn. J. Med. Mycol., 38, 175-181 (in Japanese).
8. Sugino, K., Hasegawa, T., Kimura, K., et al. (2007): Clinicopathological study of invasive pulmonary aspergillosis complicated by leukemia. J. Jpn. Assoc. Infect. Dis., 81, 261-267 (in Japanese).
9. Amitani, R., Taylor, G., Elezis, E.N., et al. (1995): Purification and characterization of ractors produced by aspergillus fumigatus which affect human clinical respiratory epithelium. Infect. Immun., 63, 3266-3271.
10. Murayama, T., Amitani, R., Ikegami, Y., et al. (1996): Suppressive effects of aspergillus fumigatus culture filtrates on human alveolar macrophages and polymorphonuclear leucocytes. Eur. Respir. J., 9, 293-300.
11. Shibuya, K., Ando, T., Hasegawa, C., et al. (2004): Pathophysiology of pulmonary aspergillosis. J. Infect. Chemother., 10, 138-145.
12. Hebisawa, A., Tamura, A., Baba, M., et al. (2003): Histopathology of saprophytic aspergillosis, including hemoptysis. Jpn. J. Chest Dis., 62, 1070-1079 (in Japanese).
13. Reichenberger, F., Habicht, J., Kaim, A., et al. (1998): Lung resection for invasive pulmonary aspergillosis in neutropenic patients with hematologic diseases. Am. J. Respir. Crit. Care Med., 158, 885-890.
14. Pidhorecky, I., Urschel, J. and Anderson, T. (2000): Resection of invasive pulmonary aspergillosis in immunocompromised patients. Ann. Surg. Oncol., 7, 312-317.